Zemits ElastiStrom

The Zemits ElastiStrom is a portable microcurrent skin-tightening device built into wearable gloves. It combines microcurrent face-lift technology with manual sculpting massage in a single system: the operator wears the gloves, so there is no machine cabinet, no probes and no multiple cords. The listing positions it as the newest generation of microcurrent skin-toning glove technology, aimed at aestheticians and massage therapists with an advanced face and body practice. **Key points:** - Modality: microcurrent delivered through gloves rather than hand-held probes. - Form factor: the entire system is worn on the hands - no machine, probes or multiple cords, per the listing. - Dual mechanism: electrical microcurrent plus manual sculpting massage performed simultaneously. - Positioning: professional use by aestheticians and massage therapists for advanced face and body treatments. - It sits at the low-risk end of this category - microcurrent is non-ablative, so it complements rather than competes with HIFU or fractional RF in a clinic menu. **Business case:** A gloves-only system has no footprint in the treatment room and no capital-heavy installation, so it is the lowest-barrier microcurrent entry point for a massage-led practice that wants to add a face-lift service without buying a cabinet device or retraining an operator on a probe-based console. **Confidence:** High - mechanism, form factor, dual action and target practitioner are all stated explicitly in the product record. **Evidence source:** Product listing `zemits-elastistrom` (id=1148), fields: lede, what_it_is, how_it_works, who_for.

The regulatory status of the Zemits ElastiStrom cannot be confirmed from the current product data. The structured fields `fda_key`, `fda_label` and `fda_tone` are empty, and the listing text contains no FDA clearance, CE marking or other certification claim. Neither clearance nor non-clearance can be concluded from this record. **Key points:** - `fda_key`, `fda_label` and `fda_tone` are all empty on the product record. - No regulatory statement appears in the lede, what_it_is, how_it_works or who_for fields - the 'one of a kind' and 'newest technology' wording is marketing, not regulatory evidence. - Microcurrent aesthetic devices are generally treated as Class II devices in the US and reach market via 510(k) premarket notification - so 'cleared', not 'approved', would be the correct term if a claim is made. - For microcurrent specifically, ask whether the supplier holds a clearance for a *facial toning / skin-tightening* indication: general microcurrent clearances often cover TENS-style pain relief, not aesthetic lifting. **⚠️ FLAG - procurement verification required.** Before purchase, obtain from the supplier: (1) the 510(k) number and the exact cleared indication wording, (2) CE marking documentation to EU MDR 2017/745 or UKCA evidence for non-US deployment, (3) a signed regulatory status letter on company letterhead for the model being purchased, (4) IEC 60601-1 electrical safety certification and the manufacturer's contraindication list for microcurrent (implanted electronic devices, pregnancy, epilepsy). **Business case:** Microcurrent is often assumed to be 'low risk so no paperwork needed' - that assumption is what voids cover. Because glove-type devices are frequently marketed for both aesthetic and therapeutic use, the cleared indication wording is the specific document that determines whether your insurance covers the service. **Confidence:** Low - no FDA or equivalent regulatory information of any kind is present in the product data, so no status can be stated. **Evidence source:** Product listing `zemits-elastistrom` (id=1148), fields: fda_key, fda_label, fda_tone, lede, what_it_is, how_it_works, who_for (all regulatory fields empty).

The product record describes the glove mechanism and the massage-based workflow but publishes no session count or interval schedule. Apply the standard microcurrent protocol for this device class and confirm the exact schedule with the manufacturer: a course of 6-10 sessions, typically twice weekly for the first 3-4 weeks and then weekly, followed by monthly maintenance. **Key points:** - Course: 6-10 sessions is the standard microcurrent course; visible lifting is cumulative and requires frequency early in the programme. - Frequency: twice weekly for the first 3-4 weeks is typical, tapering to weekly, because microcurrent results are not permanent and depend on treatment density. - Because the device is worn as gloves, treatment time is governed by the massage protocol itself - the operator performs sculpting massage while the current is delivered, so no separate probe pass is needed. - Maintenance: monthly sessions are the usual retention interval; microcurrent is a maintenance-driven service rather than a one-off fix. - The listing states the whole system is worn on the hands with no machine, probes or cords - which means faster room set-up between clients. **Business case:** Microcurrent's recurring-frequency model is a booking-engine asset: a client who comes twice weekly for a month and then monthly becomes a high-frequency regular, filling weekday gaps in the appointment book that high-ticket HIFU or RF procedures leave empty. **Confidence:** Medium - the glove mechanism and hands-only form factor are product-documented; the session count and intervals are standard clinical practice for microcurrent rather than published device specifications. **Evidence source:** Product listing `zemits-elastistrom` (id=1148), fields: lede, what_it_is, how_it_works, who_for.

The listing publishes no Fitzpatrick skin-type claim or contraindication table for the Zemits ElastiStrom, and no skin-type suitability statement appears in the `who_for` field. Microcurrent is non-ablative and does not create thermal or mechanical injury, so it is generally considered the lowest-PIH-risk modality in this category - but the key safety question for microcurrent is not skin type, it is implanted electronics. **Key points:** - No Fitzpatrick range, skin-type claim or contraindication list is present in the product record - plan on the basis of your own clinical screening protocol. - Absolute contraindications to screen for: implanted electronic devices (pacemakers, ICDs, neurostimulators, insulin pumps), pregnancy, epilepsy, active infection or open lesions in the treatment area, and metal implants in the treatment path. - Because the current passes through the operator's gloves into the client, confirm the manufacturer's guidance on grounding, glove hygiene between clients and skin preparation products - conductive gels and active serums can change current delivery. - Microcurrent does not damage the epidermis, so it is a reasonable low-risk option for Fitzpatrick IV-VI clients who want firming without pigmentation risk. - Document a signed consent that names microcurrent and any adjunct products used in the same session. **Business case:** Microcurrent's skin-type-agnostic profile makes it the safest service to market broadly, but pacemaker screening is the one question an intake form must ask - treating a client with an implanted electronic device is the classic microcurrent liability event. **Confidence:** Low to Medium - the absence of any skin-type or contraindication statement in the record is confirmed; the contraindication list and Fitzpatrick guidance are standard clinical practice for microcurrent devices, not product-documented specifications. **Evidence source:** Product listing `zemits-elastistrom` (id=1148), fields: lede, what_it_is, how_it_works, who_for.